11.5:

Ischemic Heart Disease: Overview

JoVE Core
Pharmacology
Bu içeriği görüntülemek için JoVE aboneliği gereklidir.  Oturum açın veya ücretsiz deneme sürümünü başlatın.
JoVE Core Pharmacology
Ischemic Heart Disease: Overview

186 Views

01:17 min

June 13, 2024

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.

Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing arteries, constricting the vital blood flow. When a plaque ruptures, it forms a clot that further blocks the coronary artery. This cataclysmic event can result in angina, myocardial infarction, heart failure, or sudden cardiac death.

Various factors contribute to the ominous realm of ischemic heart disease. Age, gender, family history, smoking, elevated blood pressure and cholesterol, obesity, diabetes, and stress all weave a complex web of susceptibility.

Fortitude against this silent menace lies in proactive measures. Lifestyle changes, an armor of healthy choices, fortify hearts against impending threats. Yet, modern medicine stands as a stalwart ally. Medications such as aspirin, ACE inhibitors, organic nitrates, and beta-blockers offer a shield against the insidious advances of ischemic heart disease.

Medical intervention takes a more aggressive stance when the disease tightens its grip. Invasive procedures, like angioplasty or bypass surgery, become the beacon of hope. They pave the way for restoring adequate blood flow, rescuing the heart from the clutches of this silent yet potent adversary.